## CAH: Cardinal Health, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 0.7% below STRENGTH zone (3.0-6.0%); PEG 1.97 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($199.39)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. February 2026 Options Now Available For Cardinal Health (CAH)**
- Source: Nasdaq | 20251231T172922 | Somewhat-Bullish | Relevance: 100%
- New options contracts for Cardinal Health (CAH) expiring in February 2026 are now available. Stock Options Channel identified a put contract at a $200 strike and a call contract at a $210 strike, providing potential strategies for investors looking to buy at a discount or generate income through covered calls. The article details the potential returns and risks associated with these new options.

**2. Traders Purchase High Volume of Call Options on Cardinal Health (NYSE:CAH)**
- Source: MarketBeat | 20251231T213742 | Bullish | Relevance: 100%
- Traders have significantly increased their call option purchases on Cardinal Health (NYSE:CAH), with activity up 808% to 27,965 calls. This surge follows the company's recent earnings beat, raised FY2026 guidance, and substantial institutional buying interest, contributing to a "Moderate Buy" consensus among analysts with an average price target of $209.

**3. Cardinal Health, Inc. (NYSE:CAH) Short Interest Down 22.2% in December**
- Source: MarketBeat | 20251230T225541 | Bullish | Relevance: 100%
- Cardinal Health, Inc. (NYSE:CAH) experienced a significant 22.2% decrease in short interest during December, with shorted shares totaling 4,904,967 as of December 15th, representing a short-interest ratio of 1.9 days. The company recently reported strong Q3 earnings, beating estimates with $2.55 EPS and $64.01 billion in revenue, and announced a quarterly dividend of $0.5107. Analysts currently hold a "Moderate Buy" rating for CAH with a consensus target price of $209.00.

**4. Sowell Financial Services LLC Sells 9,987 Shares of Cardinal Health, Inc. $CAH**
- Source: MarketBeat | 20251229T110025 | Bullish | Relevance: 100%
- Sowell Financial Services LLC reduced its stake in Cardinal Health, Inc. (NYSE:CAH) by 39.3%, selling 9,987 shares and retaining 15,419 shares valued at approximately $2.42 million. This move comes as Cardinal Health recently surpassed quarterly earnings expectations and provided strong FY2026 guidance, leading to several analyst target increases and a consensus "Moderate Buy" rating. The company also declared a quarterly dividend of $0.5107, payable on January 15th to shareholders of record on January 2nd.

**5. The Truth About Cardinal Health Inc.: Quiet Stock, Loud Moves â€“ Are You Sleeping On This Play?**
- Source: AD HOC NEWS | 20251231T181342 | Bullish | Relevance: 100%
- Cardinal Health Inc. recently showed significant market activity, prompting a closer look at whether this healthcare stock is a valuable investment or just a quiet performer. The article explores Cardinal Health's role in the healthcare supply chain, its recent financial performance, and its position against competitors like McKesson and AmerisourceBergen. It aims to help investors decide if this "quiet operator" is a "cop" for long-term, defensive portfolios or a "drop" for those seeking short-term gains.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $243 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 5 ($0.41M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Blackrock Inc.: 13.2% (+3.0%)
- Vanguard Group Inc: 13.0% (+0.8%)
- State Street Corpora: 5.2% (-3.0%)
- Geode Capital Manage: 2.7% (+1.5%)
- Wellington Managemen: 2.4% (+153.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.97 elevated, pricing in significant growth expectations. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $48.8B |
| Beta | 0.64 |
| 52W Range | $117.53 - $214.93 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.97 |
| Forward P/E | 18.5 |
| Current P/E | 20.9 |
| YoY Growth | 12.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.8% over 5 days). Below STRENGTH zone by 2.3pp (needs >3.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60. OFD pattern: -F0L (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.70% (CS: 80) | Neutral |
| RSI_14 | 59.8 | Neutral |
| MACD Histogram | 0.05 | Bullish |
| vs SMA20 | 1.018x | Above |
| vs SMA50 | 1.042x | Above |
| vs SMA200 | 1.266x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $205.51
- **Stop Loss:** $199.39 (3.0% risk)
- **Target:** $211.63 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 235
- **Position Value:** $48,294.85
- **Portfolio %:** 48.29%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with mixed signals requiring caution. VIX at 14.95 suggests calm markets, but record repo borrowing and narrowing breadth (51.4%) indicate stress beneath the surface. Positive yield curve (+62bps) and stable economic data support risk assets, but year-end dynamics mask true liquidity conditions.*

### Earnings

**Next:** 2026-01-29 (Est: $2.30)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.17 | $2.55 | +17.3% |
| 2025Q2 | $2.03 | $2.08 | +2.4% |
| 2025Q1 | $2.15 | $2.35 | +9.4% |
| 2024Q4 | $1.76 | $1.93 | +9.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*